Sepp-Lorenzino Laura
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Sepp-Lorenzino Laura. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| TSHA | Award / Grant | 56,623 | — | — | Jun 2, 2025 | |
| NTLA | EVP, Chief Scientific Officer | Sale | 8,966 | $12.18 | $109,206 | Jan 3, 2025 |
| NTLA | EVP, Chief Scientific Officer | Option Exercise | 3,500 | — | — | Jan 1, 2025 |
| TSHA | Award / Grant | 49,220 | — | — | May 29, 2024 | |
| NTLA | EVP, Chief Scientific Officer | Award / Grant | 37,966 | — | — | Mar 1, 2024 |
| NTLA | EVP, Chief Scientific Officer | Sale | 1,608 | $28.66 | $46,085 | Jan 8, 2024 |
| NTLA | EVP, Chief Scientific Officer | Sale | 5,532 | $29.46 | $162,973 | Jan 3, 2024 |
| NTLA | EVP, Chief Scientific Officer | Option Exercise | 3,500 | — | — | Jan 1, 2024 |
| NTLA | EVP, Chief Scientific Officer | Award / Grant | 29,938 | — | — | Mar 1, 2023 |
| NTLA | EVP, Chief Scientific Officer | Sale | 689 | $39.10 | $26,940 | Jan 4, 2023 |
| NTLA | EVP, Chief Scientific Officer | Option Exercise | 3,500 | — | — | Jan 1, 2023 |
| NTLA | EVP, Chief Scientific Officer | Option Exercise | 3,500 | — | — | Mar 1, 2022 |
| NTLA | EVP, Chief Scientific Officer | Sale | 3,932 | $157.77 | $620,352 | Aug 30, 2021 |
| NTLA | EVP, Chief Scientific Officer | Sale | 6,814 | $136.79 | $932,087 | Aug 4, 2021 |